Talphera (TLPH) Depreciation and Depletion (2021 - 2022)

Talphera's (TLPH) quarterly Depreciation and Depletion came in at $100000.0 in Q4 2022, down 66.67% year-on-year from $300000.0 in Q4 2021, and down 50.0% quarter-over-quarter from $200000.0 in Q3 2022.

Talphera (TLPH) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Talphera's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $100000.0 for Q4 2022.

  • On a quarterly basis, Depreciation and Depletion fell 66.67% year-over-year to $100000.0 in Q4 2022; TTM through Dec 2022 was $800000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $800000.0, down 27.27% from the prior year.
  • Depreciation and Depletion fell to $100000.0 in Q4 2022 per TLPH's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $300000.0 in Q2 2021 and bottomed at $100000.0 in Q4 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 36.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 21.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 28.00 Mn
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Jun 30, 2021 300,000.00